ACADIA Pharmaceuticals, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1993-07-16
- Employees
- 598
- Market Cap
- $2.6B
- Website
- http://www.acadia.com
OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
- First Posted Date
- 2024-05-20
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- ACADIA Pharmaceuticals Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT06420297
- Locations
- 🇩🇪
KJF Klinik Josefinum gGmbH, Augsburg, Germany
🇺🇸Children's of Alabama, Birmingham, Alabama, United States
🇺🇸Phoenix Children's Hospital, Phoenix, Arizona, United States
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
- First Posted Date
- 2024-01-08
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- ACADIA Pharmaceuticals Inc.
- Target Recruit Count
- 752
- Registration Number
- NCT06194799
- Locations
- 🇧🇷
Inst de Neurologia de Curitiba Hospital Ecoville, Curitiba, Brazil
🇧🇷Ruschel Medicina e Pesquisa Clínica, Rio de Janeiro, Brazil
🇧🇬DCC Higia, Pazardzhik, Bulgaria
Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
- Conditions
- Hyperphagia in Prader-Willi Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-12-15
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- ACADIA Pharmaceuticals Inc.
- Target Recruit Count
- 170
- Registration Number
- NCT06173531
- Locations
- 🇺🇸
Indiana University Hospital, Indianapolis, Indiana, United States
🇫🇷Centre Hospitalier Universitaire (CHU) de Toulouse - Hôpital des Enfants, Toulouse, France
🇺🇸Children's of Alabama, Birmingham, Alabama, United States
ACP-204 in Adults With Alzheimer's Disease Psychosis
- First Posted Date
- 2023-12-07
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- ACADIA Pharmaceuticals Inc.
- Target Recruit Count
- 1074
- Registration Number
- NCT06159673
- Locations
- 🇰🇷
Hanyang University Seoul Hospital, Seoul, Korea, Republic of
🇺🇸Khan Revive Research Institute, Rochester Hills, Michigan, United States
🇺🇸Alivation Research, LLC, Lincoln, Nebraska, United States
Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder
- Conditions
- Irritability Associated With Autism Spectrum Disorder
- Interventions
- First Posted Date
- 2022-09-27
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- ACADIA Pharmaceuticals Inc.
- Target Recruit Count
- 209
- Registration Number
- NCT05555615
- Locations
- 🇺🇸
Southwest Autism Research and Resource Center, Phoenix, Arizona, United States
🇺🇸Cortica Inc. (Glendale), Glendale, California, United States
🇺🇸Cortica Inc., San Rafael, California, United States
Pimavanserin for the Treatment of Irritability Associated with Autism Spectrum Disorder
- Conditions
- Irritability Associated with Autism Spectrum Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-08-31
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- ACADIA Pharmaceuticals Inc.
- Target Recruit Count
- 237
- Registration Number
- NCT05523895
- Locations
- 🇺🇸
Southwest Autism Research & Resource Center, Phoenix, Arizona, United States
🇺🇸Cortica Inc. (Glendale), Glendale, California, United States
🇺🇸Cortica Inc. (San Rafael), San Rafael, California, United States
Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee
- Conditions
- Osteoarthritis Pain
- Interventions
- Drug: PlaceboDrug: ACP-044 Dose BDrug: ACP-044 Dose A
- First Posted Date
- 2021-08-17
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- ACADIA Pharmaceuticals Inc.
- Target Recruit Count
- 61
- Registration Number
- NCT05008835
- Locations
- 🇺🇸
Arizona Research Center, Phoenix, Arizona, United States
🇺🇸Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Orlando, Florida, United States
🇺🇸Chase Medical Research, LLC, Waterbury, Connecticut, United States
An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- ACADIA Pharmaceuticals Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT04988867
- Locations
- 🇺🇸
Gillette Children's Hospital, Saint Paul, Minnesota, United States
🇺🇸Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy
- Conditions
- Acute Postoperative PainBunionectomy
- Interventions
- Drug: ACP-044 Dose ADrug: ACP-044 Dose BDrug: Placebo
- First Posted Date
- 2021-04-22
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- ACADIA Pharmaceuticals Inc.
- Target Recruit Count
- 239
- Registration Number
- NCT04855240
- Locations
- 🇺🇸
Anaheim Clinical Trials, Anaheim, California, United States
🇺🇸JBR Cinical Research, Salt Lake City, Utah, United States
🇺🇸Endeavor Clinical Trials of San Antonio, TX, San Antonio, Texas, United States
Open-Label Extension Study of Trofinetide for Rett Syndrome
- First Posted Date
- 2021-03-02
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- ACADIA Pharmaceuticals Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT04776746
- Locations
- 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸UC Davis MIND Institute, Sacramento, California, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States